These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7318757)

  • 1. [Value of the binding site for tritiated imipramine in the pharmacology of antidepressants].
    Zarifian E
    Encephale; 1981; 7(4 Suppl):405-7. PubMed ID: 7318757
    [No Abstract]   [Full Text] [Related]  

  • 2. High-affinity binding of 3H-imipramine in brain and platelets: relevance to depression and antidepressant drugs.
    Langer SZ; Sette M; Raisman R; Briley M
    Adv Biochem Psychopharmacol; 1982; 31():171-7. PubMed ID: 7044053
    [No Abstract]   [Full Text] [Related]  

  • 3. [3H-Imipramine binding to human platelets. A peripheral index in depressive syndromes (author's transl)].
    Zarifian E; Sechter D; Bouchami F; Cuche H; Olie JP; Susini JR; Loo H; Briley M; Raisman R; Langer SZ
    Nouv Presse Med; 1982 Apr; 11(18):1385-7. PubMed ID: 7079155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic antidepressants in treatment of the elderly.
    Hall RC; Beresford TP
    Geriatrics; 1984 Apr; 39(4):81-3, 86-8, 90 passim. PubMed ID: 6706120
    [No Abstract]   [Full Text] [Related]  

  • 5. Altered platelet 3H-imipramine binding in schizo-affective and depressive disorders.
    Suranyi-Cadotte BE; Wood PL; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Aug; 18(8):923-7. PubMed ID: 6311293
    [No Abstract]   [Full Text] [Related]  

  • 6. [Binding of tritiated imipramine to human platelets. 1 or several binding sites?].
    Scotto di Tella AM; Levy C; Lacarelle B; Tissot R
    Encephale; 1986; 12(1):13-7. PubMed ID: 3009134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are receptor studies useful for clinical practice?
    Richelson E
    J Clin Psychiatry; 1983 Sep; 44(9 Pt 2):4-9. PubMed ID: 6313632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
    Birkenhäger TK; van den Broek WW; Fekkes D; Mulder PG; Moleman P; Bruijn JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1084-8. PubMed ID: 17467132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 10. [Critical evaluation of the value and limitations of plasma assays of imipramine derivatives for therapeutic monitoring].
    Bonin B; Vandel B; Vandel S; Volmat R
    Therapie; 1986; 41(2):115-8. PubMed ID: 3726782
    [No Abstract]   [Full Text] [Related]  

  • 11. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
    Koszewska I; Beresewicz M; Puzyński S; Kalinowski A
    Psychiatr Pol; 1994; 28(1):27-38. PubMed ID: 8190817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of advantage for imipramine combined with lithium versus imipramine alone in the treatment of major depression--a double-blind controlled study.
    Shahal B; Piel E; Mecz L; Kremer I; Klein E
    Biol Psychiatry; 1996 Dec; 40(11):1181-3. PubMed ID: 8931923
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet 3H-imipramine binding and red blood cell choline in affective disorders: indications of heterogeneous pathogenesis.
    Wood PL; Suranyi-Cadotte B; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Jun; 18(6):715-9. PubMed ID: 6307404
    [No Abstract]   [Full Text] [Related]  

  • 14. Imipramine receptors in human platelets: effect of age.
    Marazziti D; Giusti P; Rotondo A; Placidi GF; Pacifici GM
    Int J Clin Pharmacol Res; 1987; 7(2):145-8. PubMed ID: 3034809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The comparative efficacy of Aurorix and amitriptyline in treating depressions].
    Iakovlev VA
    Voen Med Zh; 1997 Apr; 318(4):37-8. PubMed ID: 9221592
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hastening the onset of effects of tricyclic antidepressants by the use of bright white light].
    Prasko J; Goldmann P; Zindr R; Zindr V
    Cesk Psychiatr; 1987 Dec; 83(6):376-84. PubMed ID: 3442846
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
    Rosan TA; Mesones HL; Brengio F
    Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tricyclic antidepressants on individual symptoms.
    Welner A; Welner Z; Robins E
    J Clin Psychiatry; 1980 Sep; 41(9):306-9. PubMed ID: 7410324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil is not an antidepressant in patients resistant to tricyclic antidepressants.
    Adlersberg S; Toren P; Mester R; Rehavi M; Skolnick P; Weizman A
    Clin Neuropharmacol; 1994 Jun; 17(3):294-7. PubMed ID: 9316675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].
    Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
    Tijdschr Psychiatr; 2006; 48(4):271-81. PubMed ID: 16955991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.